MILIO, Glauco
 Distribuzione geografica
Continente #
NA - Nord America 2.929
EU - Europa 1.922
AS - Asia 1.275
SA - Sud America 257
AF - Africa 32
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.421
Nazione #
US - Stati Uniti d'America 2.894
IT - Italia 532
CN - Cina 517
SG - Singapore 432
UA - Ucraina 363
FI - Finlandia 265
BR - Brasile 218
DE - Germania 164
HK - Hong Kong 141
RU - Federazione Russa 122
IE - Irlanda 110
GB - Regno Unito 92
PL - Polonia 63
SE - Svezia 53
FR - Francia 51
IN - India 29
VN - Vietnam 29
BE - Belgio 27
TR - Turchia 27
KR - Corea 21
NL - Olanda 19
CH - Svizzera 17
CA - Canada 15
AR - Argentina 14
RO - Romania 14
ZA - Sudafrica 13
CI - Costa d'Avorio 12
MX - Messico 11
IR - Iran 10
AT - Austria 9
JP - Giappone 8
VE - Venezuela 8
BD - Bangladesh 7
ES - Italia 7
IQ - Iraq 7
PK - Pakistan 7
ID - Indonesia 6
UZ - Uzbekistan 6
LB - Libano 5
MY - Malesia 5
AU - Australia 4
BO - Bolivia 4
CO - Colombia 4
GR - Grecia 3
IL - Israele 3
KE - Kenya 3
PY - Paraguay 3
UY - Uruguay 3
AM - Armenia 2
CR - Costa Rica 2
DZ - Algeria 2
EC - Ecuador 2
HR - Croazia 2
JO - Giordania 2
LT - Lituania 2
MA - Marocco 2
PA - Panama 2
PT - Portogallo 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CL - Cile 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
MM - Myanmar 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
QA - Qatar 1
RS - Serbia 1
Totale 6.421
Città #
Ashburn 336
Chandler 279
Singapore 228
Fairfield 222
Jacksonville 198
Ann Arbor 170
Woodbridge 163
Wilmington 141
Hong Kong 136
Houston 113
Dublin 110
Medford 85
Nanjing 77
Seattle 77
Cambridge 71
Des Moines 70
Palermo 62
Beijing 59
Princeton 53
Hefei 52
Zgierz 52
Tulsa 50
Los Angeles 46
Moscow 44
Boardman 34
New York 30
Dearborn 29
Brussels 26
Dallas 25
Jinan 25
Buffalo 24
San Diego 24
Shenyang 24
Milan 22
Altamura 21
Hebei 21
Changsha 20
Nanchang 20
San Mateo 20
Jiaxing 19
Rome 19
The Dalles 18
Izmir 17
Tianjin 14
Lawrence 13
Santa Clara 13
Seongnam 13
Abidjan 12
Columbus 12
São Paulo 12
Hanoi 11
Johannesburg 11
Ningbo 11
Pune 11
Shanghai 11
Warsaw 11
Zhengzhou 11
Verona 10
Ludwigshafen am Rhein 9
Munich 9
Atlanta 8
Auburn Hills 8
Catania 8
Taizhou 8
Tokyo 8
Bari 7
Council Bluffs 7
Guangzhou 7
Ho Chi Minh City 7
Lanzhou 7
Orem 7
Redondo Beach 7
Tehran 7
Denver 6
Falls Church 6
Haikou 6
Kunming 6
London 6
Poplar 6
Rio de Janeiro 6
Venice 6
Affoltern am Albis 5
Brasília 5
Bremen 5
Florence 5
Lahore 5
Mykolayiv 5
Phoenix 5
Redwood City 5
Reseda 5
Saint Petersburg 5
Seoul 5
Taiyuan 5
Torino 5
Chennai 4
Chicago 4
Enna 4
Frankfurt am Main 4
Hangzhou 4
Kumar 4
Totale 3.759
Nome #
Iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis and the quality of life: a new therapeutic protocol 228
Ischemia critica cronica e vasculopatia ischemica polidistrettuale 205
Modello di percorso diagnostico e terapeutico per l'arteriopatia obliterante periferica 203
Antiplatelet treatment in ischemic stroke treatment. 197
Critical limb ischaemia: definition and natural hystory 189
Asymptomatic Carotid Lesions and Aging: Role of Hypertension and Other Traditional and Emerging Risk Factors 184
Changes of arterial hemodynamics in patients with type 2 diabetes mellitus or impaired glucose tolerance 184
Asymptomatic carotid lesions and aging: role of hypertension and other traditional and emerging risk factors 180
Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: The Duration of Anticoagulation based on Compression Ultrasonography (DACUS) study 174
Pharmacological Treatment of Patients with Chronic Critical Limb Ischemia: L-Propionyl-Carnitine Enhances the Short-Term Effects of PGE-1 172
Subclavean stenosis/occlusion in patients with subclavean steal and previous by pass of internal mammary interventricular anterior artery: medical or surgery treatment? 171
Immunohistochemical expression of iNOS and metalloproteinases MMP2 and MMP9 in abdominal inflammatory aortic Aneurysms 144
Superficial venous thrombosis: Prevalence of common genetic risk factors and their role on spreading to deep veins 142
Absence of residual vein thrombosis after an episode of idiopatic deep vein thrombosis: short-term anticoagulation is safe. The extended DACUS Study 140
Effetti dell’iloprost sulla disfunzione leucocitaria nella sclerodermia. 135
Calf vein thrombosis: optimal duration of treatment 135
Absence of residual vein thrombosis after an episode of idiopatic deep vein thrombosis: short-term anticoagulation is safe. The extended DACUS study. 134
Response to letter by Drs. Mohammed Abbas, Maria Sessa, and Francesco Corea 128
Comportamento della eNOS e dell'iNOS nella genesi e mantwnimento delle ulcere venose degli arti inferiori 126
Modello di percorso diagnostico e terapeutico per la trombosi venosa superficiale 125
Residual vein thrombosis assessment estabilishes the optimal duration of oral anticoagulants in patients with idiopatic or provoked deep vein thrombosis 124
Serial 2-point ultrasonography plus D-dimer vs whole-leg color-coded Doppler ultrasonography for diagnosing suspected symptomatic deep vein thrombosis: a randomized controlled trial 123
Stress ossidativo in pazienti con sclerodermia: effetti dell’iloprost. 121
La terapia metabolica nel trattamento dell'ischemia critica cronica degli arti inferiori: la L-propionilcarnetina potenzia gli effetti della PGE-1 112
Residual vein thrombosis assessment establishes the otpimal duration of oral anticoagulants in patients with idiopathic or provoked deep vein thrombosis 111
Aspetti fisiopatologici dell'ulcera venosa 111
Sodium thiosulfate not always resolves calciphylaxis: an ambiguous response 111
MTHFR allele 677T band risk of abdominal aortic aneurysm 110
Moderno approccio alla trombosi venosa superficiale 107
Efficacy of the treatment with prostaglandin E-1 in venous ulcers of the lower limbs 107
Effetti emoreologici del trattamento con iloprost in pazienti con fenomeno di Raynaud secondario a sclerodermia. 105
Immunohistochemical expression of iNOS and eNOS in the venous ulcers related to chronic venous insufficiency (CVI). 103
Calf vein thrombosis: optimal duration of tretment 102
Superficial venous thrombosis: role of genetic risk factors on spreeding to deep veins 100
null 100
Calf veins thrombosis: optimal duration of treatment 93
THE EFFECTS OF PROSTAGLANDIN E-1 IN PATIENTS WITH INTERMITTENT CLAUDICATION 91
Trombosi venosa superficiale ed estensione al circolo profondo: ruolo dei fattori di rischio genetici 91
Residual vein thrombosis estabilishes the optimal duration of oral anticoagulants for the treatment od DVT 90
Residual Vein Thrombosis Assessment Establishes the Optimal Duration of Oral Anticoagulants in Patients with Idiopathic or Provoked Deep Vein Thrombosis: a Randomized, Controlled Trial 89
SUPERFICIAL VENOUS THROMBOSIS: ROLE OF GENETIC RISK FACTORS ON SPREADING TO DEEP VEINS 85
Metabolic therapy in the treatment of chronic critical limbs ischemia: the L-propionyl-carnitine enhances the effects of PGE-1 84
Residual vein thrombosis assessment estabilishes the optimal duration of oral anticoagulants in patients with idiopatic or provoked deep vein thrombosis. a randomized, controlled trial 78
Trattamento delle manifestazioni vascolari nella Sclerosi Sistemica e qualità della vita: nuovo protocollo 77
Ischemia critica e connettiviti: presupposti fisiopatologici per un protocollo di trattamento 77
The effects of Prostaglandin E-1in patients with intermittent claudication 76
Peso dei fattori di rischio nell’evoluzione dell’aterosclerosi preclinica 75
The effects Prostaglandine E-1 in patients with intermittent claudication 73
TROMBOSI PROFONDA SUPERFICIALE ED ESTENSIONE AL CIRCOLO PROFONDO: RUOLO DEI FATTORI DI RISCHIO GENETICI 72
Superficial venous thrombosis and spreading to deep veins: role of genetic risk factors for venous thromboembolism 70
Il trattamento domiciliare della TVP 68
METABOLIC THERAPY IN THE TREATMENT OF CHRONIC CRITICAL LIMBS ISCHEMIA OF THE LOWER LIMBS. THE L-PROPIONYL-CARNITINE ENHANCES THE EFFECTS OF PGE-1 63
Rilievi emoreologici nella sclerosi sistemica. 63
NO and Chronic Venous Insufficiency (CVI): Immunohistochemical Evaluation of iNOS and eNOS Isofroms in the Venous Ulcers. Clinical and Therapeutical Possible Implications 63
null 57
Totale 6.478
Categoria #
all - tutte 21.969
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.969


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021354 0 0 0 0 0 32 59 31 77 20 71 64
2021/2022539 18 139 5 35 20 7 27 23 65 68 20 112
2022/2023762 82 97 9 87 86 117 64 63 94 16 41 6
2023/2024301 14 48 17 31 21 79 33 7 1 7 5 38
2024/2025882 19 54 30 109 55 22 99 73 56 70 91 204
2025/20261.081 190 54 182 256 270 129 0 0 0 0 0 0
Totale 6.478